Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
28 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsFDA grants Breakthrough Device Designation for Roche`s Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer`s disease
(WorldNews Switzerland)

 
 

20 july 2018 08:27:11

 
FDA grants Breakthrough Device Designation for Roche`s Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer`s disease
(WorldNews Switzerland)
 


Basel, 20 July 2018 FDA grants Breakthrough Device Designation for Roche`s Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer`s disease Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today, that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Elecsys® ß-Amyloid (1-42) CSF and Elecsys® Phospho-Tau (181P) CSF. These in vitro diagnostic immunoassays are for the measurement of the ß-Amyloid (1-42) and Phospho-Tau concentrations in cerebrospinal fluid (CSF) in adult patients with cognitive impairment who are being evaluated for Alzheimer`s disease (AD) or other causes of dementia. Currently, the diagnosis of AD is...


 
13 viewsCategory: General > Europe > Switzerland
 
Bachem: Footprint in Asia
(WorldNews Switzerland)
Roche to present new data demonstrating the breadth and depth of its Alzheimer´s programme at the upcoming Alzheimer`s Association International Conference
(WorldNews Switzerland)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten